NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.895
-0.055 (-1.86%)
Apr 29, 2026, 1:14 PM EDT - Market open
NRx Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 7.8 | 1.44 | 4.6 | 20.05 | 27.61 | Upgrade
|
| Cash & Short-Term Investments | 7.8 | 1.44 | 4.6 | 20.05 | 27.61 | Upgrade
|
| Cash Growth | 440.33% | -68.60% | -77.09% | -27.35% | 1384.94% | Upgrade
|
| Accounts Receivable | 0.16 | - | - | - | - | Upgrade
|
| Other Receivables | - | - | 0.01 | 0.01 | - | Upgrade
|
| Receivables | 0.16 | - | 0.01 | 0.01 | - | Upgrade
|
| Prepaid Expenses | 0.59 | 1.04 | 1.41 | 3.77 | 4.6 | Upgrade
|
| Other Current Assets | 0.34 | 0.82 | 0.87 | 1.97 | 0.51 | Upgrade
|
| Total Current Assets | 8.89 | 3.3 | 6.88 | 25.8 | 32.71 | Upgrade
|
| Property, Plant & Equipment | 0.7 | 0.01 | - | - | - | Upgrade
|
| Long-Term Investments | 0.4 | - | - | - | - | Upgrade
|
| Goodwill | 1.79 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 0.93 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.25 | 0.34 | 0.43 | 0.02 | 0.02 | Upgrade
|
| Total Assets | 12.96 | 3.65 | 7.32 | 25.82 | 32.73 | Upgrade
|
| Accounts Payable | 4.27 | 4.13 | 4.63 | 2.08 | 3.69 | Upgrade
|
| Accrued Expenses | 6.18 | 6.13 | 5.24 | 5.77 | 2.84 | Upgrade
|
| Current Portion of Long-Term Debt | - | 1.25 | 9.16 | 7.7 | 0.52 | Upgrade
|
| Current Portion of Leases | 0.32 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 17.81 | 10.35 | 0.02 | 0.04 | 4.87 | Upgrade
|
| Total Current Liabilities | 28.58 | 21.86 | 19.05 | 15.59 | 11.92 | Upgrade
|
| Long-Term Debt | - | 5.01 | - | 2.82 | - | Upgrade
|
| Long-Term Leases | 0.32 | - | - | - | - | Upgrade
|
| Total Liabilities | 28.89 | 26.87 | 19.05 | 18.41 | 11.92 | Upgrade
|
| Common Stock | 0.03 | 0.02 | 0.01 | 0.07 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 290.93 | 255.04 | 241.41 | 230.34 | 203.99 | Upgrade
|
| Retained Earnings | -306.9 | -278.27 | -253.15 | -223 | -183.24 | Upgrade
|
| Comprehensive Income & Other | - | - | -0 | - | - | Upgrade
|
| Total Common Equity | -15.94 | -23.22 | -11.74 | 7.41 | 20.81 | Upgrade
|
| Shareholders' Equity | -15.94 | -23.22 | -11.73 | 7.41 | 20.81 | Upgrade
|
| Total Liabilities & Equity | 12.96 | 3.65 | 7.32 | 25.82 | 32.73 | Upgrade
|
| Total Debt | 0.63 | 6.26 | 9.16 | 10.53 | 0.52 | Upgrade
|
| Net Cash (Debt) | 7.17 | -4.81 | -4.57 | 9.53 | 27.09 | Upgrade
|
| Net Cash Growth | - | - | - | -64.82% | 2450.57% | Upgrade
|
| Net Cash Per Share | 0.33 | -0.45 | -0.60 | 1.45 | 5.77 | Upgrade
|
| Filing Date Shares Outstanding | 33.03 | 16.92 | 9.45 | 7.06 | 6.66 | Upgrade
|
| Total Common Shares Outstanding | 31.7 | 14.59 | 8.27 | 6.54 | 5.88 | Upgrade
|
| Working Capital | -19.69 | -18.56 | -12.16 | 10.21 | 20.79 | Upgrade
|
| Book Value Per Share | -0.50 | -1.59 | -1.42 | 1.13 | 3.54 | Upgrade
|
| Tangible Book Value | -18.66 | -23.22 | -11.74 | 7.41 | 20.81 | Upgrade
|
| Tangible Book Value Per Share | -0.59 | -1.59 | -1.42 | 1.13 | 3.54 | Upgrade
|
| Machinery | 0.09 | 0.03 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.